The last-mile delivery challenge in three-dimensional (3D) multi-floor building environments has a significant impact on logistics efficiency. Although autonomous delivery robots (ADRs) have been widely adopted to address last-mile logistics, most existing studies focus on optimizing ADR routing in simplified two-dimensional environments. Moreover, optimal layout of goods within the robot's physical containers brings another challenge. Hence, this paper formalizes the Discrete Capacity Vehicle Routing Problem with Simultaneous Delivery-Pickup and Soft Time Windows (DCVRP-SDP-STW) in a 3D environment. To achieve high-quality solutions, we propose an improved ant colony optimization algorithm that considers spatiotemporal multi-stage clustering characteristics, leading to a significant reduction in computation time. A data preprocessing framework is also developed to convert real-world architectural topologies into navigable 3D routing networks. To validate the proposed model and algorithm, we conducted a case study in Nanjing. The results show that the algorithm can improve optimization outcomes by 23% to 94% compared to pre-optimization results based on the proximity principle, which can contribute to the advancement of efficient and intelligent autonomous delivery systems.
Citation: Qi Hong, Hongyi Zhao, Shiyu Chen, Aya Selmoune, Kai Huang. Optimizing routing for autonomous delivery and pickup vehicles in three-dimensional space[J]. Electronic Research Archive, 2025, 33(4): 2668-2697. doi: 10.3934/era.2025118
[1] | Dawei Liu, Zeeshan Shaukat, Rashid Hussain, Mahwish Khan, Stephen L. Gregory . Drosophila as a model for chromosomal instability. AIMS Genetics, 2015, 2(1): 1-12. doi: 10.3934/genet.2015.1.1 |
[2] | Tin Tin Su . Non-autonomous consequences of cell death and other perks of being metazoan. AIMS Genetics, 2015, 2(1): 54-69. doi: 10.3934/genet.2015.1.54 |
[3] | Xianjue Ma . Context-dependent interplay between Hippo and JNK pathway in Drosophila. AIMS Genetics, 2014, 1(1): 20-33. doi: 10.3934/genet.2014.1.20 |
[4] | Helena E. Richardson . Drosophila models of cancer. AIMS Genetics, 2015, 2(1): 97-103. doi: 10.3934/genet.2015.1.97 |
[5] | John E. La Marca, Wayne Gregory Somers . The Drosophila gonads: models for stem cell proliferation, self-renewal, and differentiation. AIMS Genetics, 2014, 1(1): 55-80. doi: 10.3934/genet.2014.1.55 |
[6] | Jue Er Amanda Lee, Linda May Parsons, Leonie M. Quinn . MYC function and regulation in flies: how Drosophila has enlightened MYC cancer biology. AIMS Genetics, 2014, 1(1): 81-98. doi: 10.3934/genet.2014.1.81 |
[7] | Carlos Estella, Antonio Baonza . Cell proliferation control by Notch signalling during imaginal discs development in Drosophila. AIMS Genetics, 2015, 2(1): 70-96. doi: 10.3934/genet.2015.1.70 |
[8] | Francesca Froldi, Milán Szuperák, Louise Y. Cheng . Neural stem cell derived tumourigenesis. AIMS Genetics, 2015, 2(1): 13-24. doi: 10.3934/genet.2015.1.13 |
[9] | Tú Nguyen-Dumont, Jenna Stewart, Ingrid Winship, Melissa C. Southey . Rare genetic variants: making the connection with breast cancer susceptibility. AIMS Genetics, 2015, 2(4): 281-292. doi: 10.3934/genet.2015.4.281 |
[10] | Xiaochen Fan, David A F Loebel, Heidi Bildsoe, Emilie E Wilkie, Jing Qin, Junwen Wang, Patrick P L Tam . Tissue interactions, cell signaling and transcriptional control in the cranial mesoderm during craniofacial development. AIMS Genetics, 2016, 3(1): 74-98. doi: 10.3934/genet.2016.1.74 |
The last-mile delivery challenge in three-dimensional (3D) multi-floor building environments has a significant impact on logistics efficiency. Although autonomous delivery robots (ADRs) have been widely adopted to address last-mile logistics, most existing studies focus on optimizing ADR routing in simplified two-dimensional environments. Moreover, optimal layout of goods within the robot's physical containers brings another challenge. Hence, this paper formalizes the Discrete Capacity Vehicle Routing Problem with Simultaneous Delivery-Pickup and Soft Time Windows (DCVRP-SDP-STW) in a 3D environment. To achieve high-quality solutions, we propose an improved ant colony optimization algorithm that considers spatiotemporal multi-stage clustering characteristics, leading to a significant reduction in computation time. A data preprocessing framework is also developed to convert real-world architectural topologies into navigable 3D routing networks. To validate the proposed model and algorithm, we conducted a case study in Nanjing. The results show that the algorithm can improve optimization outcomes by 23% to 94% compared to pre-optimization results based on the proximity principle, which can contribute to the advancement of efficient and intelligent autonomous delivery systems.
One of the most important goals in the battle against cancer is to prevent metastasis. Metastatic tumor cells employ a complex repertoire of behaviors that allow them to break free of the primary tumor and disseminate throughout the body to establish secondary tumors. Since it is these metastases that are the primary cause of cancer related deaths, understanding the genetic regulation of metastasis is crucial. In this quest, genetic model organisms such as the vinegar fly, Drosophila melanogaster, can play a key role. For years, studies in the fly have contributed greatly towards our understanding of many basic cellular processes such as the cell-cycle, apoptosis, polarity, and motility, and have led to the identification and elucidation of signaling pathways that play a central role in cancer (e.g. Hippo, Wingless (Wg)/Wnt, Notch, Ras, Hedgehog etc.). In this review I highlight the many ways in which the fly is also helping us understand metastasis.
Although metastasis can affect tumors of both epithelial and non-epithelial origin, the focus of this review will be the metastasis of epithelial tumors, which account for the majority of cancers. To metastasize, epithelial tumor cells must break free of the epithelial constraints and become migratory and invasive, allowing them to break through the basement membrane, and migrate into the adjacent tissue. To progress from local invasion to metastasis to distant sites, cells must then enter blood vessels or lymphatic vessels (i.e. intravasate), and subsequently leave the vessels (extravasate) to reinitiate proliferation and establish the secondary tumor mass.
In recent years a popular model for this process has been that metastasizing cells lose their epithelial characteristics, such as apico-basal polarity and the zonula adherens (ZA) (the circumferential belt of E-Cadherin-based cell-cell adhesive junctions) and become dissociated, migratory, mesenchymal cells. This characteristic sequence of events is known as an epithelial mesenchymal transition (EMT), and is also crucial during animal development, in events such as gastrulation and vertebrate neural crest formation [1]. Since secondary tumors exhibit epithelial characteristics, however, this model also includes the idea that cancer cells can undergo the reverse transition of mesenchymal epithelial transition (MET) at the secondary site, and this is thought to be important for the growth of the secondary tumor [2,3]. More recently, however, this EMT model for metastasis is being revised, since in many cases it is clear that metastatic cells do not undergo a " full EMT" but instead continue to express epithelial markers and migrate as collectives [4]. Similarly, during development there exist many examples where epithelial cells undergo only a partial EMT resulting in an intermediate phenotype, with both epithelial and mesenchymal characteristics. It has also been suggested that metastasis might involve cooperation between " EMT cells" , which provide tumors with the necessary invasive properties, and " non-EMT cells" , which are responsible for the formation of secondary tumors [5,6,7]. Alternatively, there exist tumors that are highly invasive but still express full epithelial features, such as those expressing podoplanin [8,9]. Similar events occur in development where epithelial sheets migrate due to leading edge cell motility. These considerations are leading to a more widely applicable concept of epithelial plasticity, in which cells can move backwards and forwards along an axis of epithelial-mesenchymal traits [10].
To achieve the complex sequence of behaviors required for metastasis, cancer cells take advantage of existing genetic regulatory networks used during development. For example in flies, the transcription factor Twist sits at the apex of a hierarchy of regulatory events that together lead mesodermal cells to fold inwards, undergo an EMT, and become migratory. Thus, when a cancer cell upregulates a gene like Twist1, it can put into play a coordinated and complex genetic program that together promotes metastasis. Consequently, significant insight into metastasis can be gained by studying analogous processes during development.
In this review the focus will be on the first stage of metastasis, when cells lose their epithelial properties and become migratory, i.e. the EMT. The subsequent process of migration is obviously also crucial, and readers are referred to other reviews on cell migration in Drosophila [11,12,13,14,15,16]. I begin by covering several normal developmental events in the fly that have provided key insights into the fundamental mechanisms of EMT and metastasis. The second part of the review covers situations in which researchers induce metastatic behavior via specific genetic perturbations. Since the events of metastasis depend greatly on the surrounding cellular microenvironment, the ability to make such perturbations in the context of a normal, in vivo, cellular environment is one of the great strengths of Drosophila as a system for modelling for metastasis. Conversely, it must be recognized that there are inherent limitations in how completely one can model metastasis in flies. A major difference is that flies have an open circulatory system and therefore do not possess blood or lymphatic vessels, which are key factors in metastasis.
In this section I review four normal developmental events that involve loss of epithelial structure/integrity and acquisition of cell motility. These are mesoderm formation, endoderm formation, wing disc eversion, and border cell delamination (Figure 1).
The question arises as to whether these events should be classified as EMT or partial-EMT. A widely used definition of full EMT is that it involves complete loss of E-Cadherin (E-Cad) expression due to transcriptional repression by an EMT-inducing transcription factor such as Snail [17]. According to this definition, none of these events would be classified as EMTs. Although mesoderm formation does involve Snail repression of shotgun (shg), the Drosophila orthologue of E-Cad (see Table 1 for list of Drosophila genes and human orthologues), and epithelial structure and apico-basal polarity are completely lost, levels of E-Cad protein remain high and may even be important for the migration. In the endodermal EMT, cells do lose epithelial structure and polarity, but there is no transcriptional repression of shg and E-Cad is again maintained at significant levels. In disc eversion, epithelial cells in some regions undergo dismantling of ZAs and loss of apico-basal polarity, but away from this area the epithelium persists, and it is not known whether Snail-family transcription factors are involved. Finally, in the case of the border cells, a cluster of cells breaks free of the follicular epithelium, but their subsequent migration is as a structured, and tightly adhered collective, which is dependent upon E-Cad.
* These human orthologs were curated from Drosophila literature. All others were extracted from Ensembl Biomart. | |||
Gene symbol | Gene name | Molecular function | Human orthologues |
ab | abrupt | BTB-Zinc Finger Transcription Factor | |
Abl | Abl tyrosine kinase | Cytoplasmic tyrosine kinase | ABL1, ABL2 |
arm | armadillo | Catenin (adherens junction component) | CTNNB1 |
ban | bantam | microRNA | |
ben | bendless | Part of Ben/dUev1a E2 ubiquitin-conjugating enzyme complex | UBE2Z |
bsk | basket | JUN kinase | MAPK8, MAPK9, MAPK10 |
N-Cad | N-Cadherin | N-Cadherin | CDH2 * |
Cdc42 | Cdc42 | Rho GTPase | CDC42 |
Ced-12 | Ced-12 | PH-domain protein, complexes with DOCK180 | ELMO1, ELMO2, ELMO3 |
cher | cheerio | Filamin protein | FLNA, FLNB, FLNC |
chic | chickadee | Profilin protein | PFN1, PFN2, PFN3, PFN4 * |
conu | conundrum | Rho GAP | ARHGAP40 |
crb | crumbs | transmembrane apical polarity complex protein | CRB1, CRB2 |
Crk | Crk | SH2/SH3-containing adaptor protein | CRKL |
Csk | C-terminal Src kinase | cytoplasmic tyrosine kinase, negative regulator of Src | CSK |
cta | concertina | Gα12/13 subunit | GNA12, GNA13 |
dlg1 | discs large 1 | MAGUK scaffolding protein, part of Scrib/Dlg/Lgl complex | DLG4 |
dome | domeless | gp130-like JAK/STAT Receptor | |
dpp | decapentaplegic | TGF ligand | BMP2, BMP4 |
EcR | Ecdysone receptor | part of the EcR/Usp ecdysone receptor heterodimer | NR1H4 |
egr | eiger | Tumor Necrosis Factor | |
ena | enabled | actin-associated protein | VASP, ENL |
fog | folded gastrulation | secreted protein | |
fra | frazzled | Netrin receptor | DCC, NEO1 |
hep | hemipterous | Jun kinase kinase | MAP2K7 |
HIF-1α | Hypoxia Induced Factor 1α | Hypoxia Induced Factor | HIF-1α * |
htl | heartless | FGF Receptor | FGFR1, FGFR2, FGFR3, FGFR4 |
Jra (Jun) | Jun-related antigen | part of Jun/Fos (AP-1) transcription factor | JUN, JUNB, JUND |
Kay(Fos) | kayak | part of JUN/FOS (AP-1) transcription factor | FOS, FOSL1, FOSL2, FOSB |
l(2)gl | lethal (2) giant larvae | Scaffolding protein, part of Scrib/Dlg/Lgl complex | LLGL1, LLGL2 |
mbc | myoblast city | DOCK-family GTP Exchange Factor (GEF) | DOCK1, DOCK2, DOCK5 |
mist | mesoderm-invagination signal transducer | G-protein-coupled Receptor | |
Mmp1 | Matrix metalloproteinase 1 | Matrix Metalloproteinase | MMP19, MMP28 * |
Mmp2 | Matrix metalloproteinase 2 | Matrix Metalloproteinase | MMP1, MMP3, MMP7, MMP8, MMP10, MMP11, MMP13, MMP14, MMP15, MMP17, MMP20, MMP24, MMP25, MMP27, AP000789.1 |
Moe | Moesin | ERM-family protein, F-Actin/trans-membrane linker | EZR, MSN, RDX |
N | Notch | Notch receptor | NOTCH1, NOTCH2, NOTCH3, NOTCH4, SNED1 |
NetA | Netrin-A | Netrin, secreted chemotactic factor | NTN1, NTN3, NTN4, NTN5, NTNG1, NTNG2, LAMB3 |
NetB | Netrin-B | Netrin, secreted chemotactic factor | NTN1, NTN3, NTN4, NTN5, NTNG1, NTNG2, LAMB3 |
p120ctn | Adherens junction protein p120 | p120 Catenin (adherens junction component) | CTNND1, CTNND2, PKP1, PKP2, PKP3, PKP4, ARVCF |
par-1 | par-1 | serine/threonine kinase | MARK1, MARK2, MARK3, MARK4 |
pbl | pebble | Rho GTP Exchange Factor (RhoGEF) | ECT2 |
ph-d | polyhomeotic distal | Polycomb Group repressor complex subunit | PHC1, PHC2, PHC3 |
Pvr | PDGF- and VEGF-receptor related | PDGF/VEGF-Receptor Tyrosine Kinase | PDGFRA, PDGFRB, FLT1, FLT3, FLT4, CSF1R, KDR, KIT |
pyr (FGF8-like2) | pyramus | FGF ligand | |
Rac1 | Rac1 | Rho GTPase | RAC1, RAC2, RAC3 |
Ras85D | Ras oncogene at 85D | Ras GTPase | ERAS, KRAS, HRAS, HRAS |
Rho1 | Rho1 | Rho GTPase | RHOA, RHOB, RHOC |
RhoGEF2 | Rho guanine nucleotide exchange factor 2 | Rho GTP Exchange Factor (RhoGEF) | ARHGEF1, ARHGEF11, ARHGEF12 |
scb | scab | Integrin alpha-subunit | ITGA1, ITGA11, ITG4, ITGA2, ITGAD, ITGAL, ITGAE, ITGA9, ITGA10, ITGAX, ITGAM |
scrib | scribbled | LRR/PDZ scaffolding protein, part of Scrib/Dlg/Lgl complex | SCRIB, LRRC1 |
sdt | stardust | MAGUK family of scaffolding protein, part of Crumbs apical complex | MPP5 |
shg (E-Cad) | shotgun | Epithelial Cadherin (adherens junction component) | CDH1 * |
Sin3A | Sin3A | Sin3-family Histone Deacetylase | SIN3A, SIN3B |
slbo | slow border cells | C/EBP transcription factor | |
slik | Sterile20-like kinase | Sterile20 kinase | SLK, SLK10 |
slpr | slipper | Jun kinase kinase kinase | MAP3K9, MAP3K10, MAP3K11, RP5-862P8.2 |
sna | snail | Snail family transcription factor | SNAI1, SNAI2, SNAI3 |
Socs36E | Suppressor of cytokine signaling at 36E | cytoplasmic suppressors of JAK/STAT signaling | SOCS4, SOCS5 |
srp | serpent | GATA-factor | hGATA4, hGATA5, hGATA6 * |
T48 | Transcript 48 | membrane protein | |
tai | taiman | Steroid receptor co-activator | AIB1 * |
Tak1 | TGF-beta activated kinase 1 | Jun kinase kinase kinase | MAP3K7 |
ths (FGF8-like1) | thisbe | FGF ligand | |
Traf6 | TNF-receptor-associated factor 6 | TNF Receptor-associated factor | |
tsr | twinstar | Cofilin/Actin Depolymerising Factor | CFL1, CFL2, ADF * |
twi | twist | Twist transcription factor | TWIST1, TWIST2 |
Uev1A | Ubiquitin-conjugating enzyme variant 1A | Part of Ben/dUev1a E2 ubiquitin-conjugating enzyme complex | UBE2V1, UBE2V2 |
Upd | Unpaired | Interleukin-like JAK/STAT ligand | IL-6 * |
upd2 | unpaired 2 | Interleukin-like JAK/STAT ligand | IL-6 * |
upd3 | unpaired 3 | Interleukin-like JAK/STAT ligand | IL-6 * |
usp | ultraspiracle | part of the EcR/Usp ecdysone receptor heterodimer | RXRA, RXRB, RXRG |
wg | wingless | WNT/Wingless secreted ligand | WNT1 |
wgn | wengen | TNF Receptor | |
zip | zipper | non-muscle myosin II |
For the sake of this review, a broader definition of EMT will be adopted, in which EMT entails only the loss of epithelial structure (i.e. apico-basal polarity and ZAs) and gain of motility. Thus the mesoderm and endoderm will be considered EMTs, while the eversion and border cell delamination will be considered partial EMTs. Regardless of the terminology, these four events represent a valuable and diverse set of EMT paradigms involving four, distinct genetic regulatory hierarchies. In addition to these EMTs, there are several other developmental events in which epithelial cells exhibit plasticity but still maintain ZA connections with their original neighbors, such as the branching morphogenesis of the trachea, and the epithelial sheet migrations of dorsal and thorax closure. While these involve cellular behaviors that are relevant to metastasis, they will not be covered here and the reader is referred to recent reviews [18,19].
The first EMT during Drosophila embryogenesis, and indeed the first for any animal, occurs at gastrulation. In Drosophila, a ventral band of cells constrict their apical surface creating a furrow which folds inwards. Once internalized, mesodermal cells undergo a wave of cell division as they lose their epithelial structure (Figure 1A), and then they migrate laterally upon the inner surface of the ectoderm. All of these behaviors are under the control of two key transcription factors that are specifically expressed in presumptive mesodermal cells, Twist and Snail. These genes, which were identified over 30 years ago [20], have since become two of the most important cancer genes in humans [21,22]. The fact that over 1000 cancer papers have now been published on Twist and Snail family proteins, half of these within the last 3 years, highlights the importance of the mesodermal EMT, as a model system for cancer studies.
As a master regulator of mesodermal cell fate, Twist activates hundreds of downstream targets, including snail [23]. For some of these, the link to cell behaviors has been determined. The initial apical constriction that drives invagination begins with the Twist target folded-in-gastrulation (fog). Fog is a secreted protein that activates the G-protein Coupled Receptor, mesoderm invagination signal transducer (mist), which is itself a Snail target. This is thought to lead to activation of the Gα subunit Concertina, and subsequent activation and recruitment to the membrane of RhoGEF2, facilitated by another Twist target the transmembrane protein T48 [24,25]. Shortly after internalization, the epithelial tube undergoes a collective EMT, in which the mesodermal cells lose their epithelial structure en masse, and subsequently spread out over the underlying ectoderm. This migration is dependent upon activation of the FGF Receptor Heartless (Htl), in response to two FGF8-like ligands, Pyramus and Thisbe, and upon the RhoGEF Pebble (Pbl) [reviewed in 16]. Interestingly, although Pbl plays a positive role in migration, too much Pbl at the earlier, furrowing stage causes phenotypes. pbl is actually one of the genes that is repressed by Snail in the presumptive mesoderm, and when this repression is blocked, or when Pbl is overexpressed, internalization is disrupted [26].
The mesodermal EMT exemplifies one of the classic hallmarks of EMT in both development and cancer: cadherin switching [27]. This is the process in which E-Cad is repressed, while N-Cadherin (N-Cad), a form associated with non-epithelial cells such as neurons and mesodermal cells, is upregulated. Loss or mutation of E-Cad, and upregulation of N-Cad [28,29], are strongly associated with metastasis and poor prognosis. In the case of Drosophila mesodermal cells, Snail represses shg/E-Cad while Twist upregulates N-Cad [30]. A natural assumption of the mechanism of mesodermal EMT, therefore, would be that Snail-dependent repression of E-Cad adhesion drives the EMT, and the switch to N-Cad is important for the subsequent migration. However, two recent publications are challenging our notions about this canonical EMT event.
Firstly, the functional importance of the cadherin switch has recently been put to the test [31]. Surprisingly, neither expression of N-Cad nor loss of E-Cad is necessary for the EMT or for the subsequent segregation of mesoderm and ectodermal cells. In fact, the EMT can proceed normally even when E-Cad is overexpressed, pointing to powerful, but as yet unidentified, factors driving the dismantling of the ZA. Since E-Cad is still expressed in wild type mesodermal cells, and even appears to play a positive role in the migration [32], the mesodermal EMT has been referred to as a partial EMT. However, although mesodermal cells do move together, and might be thought of as a collective migration event, single cell labelling experiments have provided evidence that mesodermal cells also have the capacity to migrate independently from one another [33]. Given that transcriptional repression of E-Cad does not seem important, an outstanding question is: what drives the ZA breakdown. Two factors that are known to contribute at least partly to this process are Htl, and the round of cell division that the cells undergo. Previous studies using mutants for string (stg), the Drosophila cdc25 ortholog, have shown that the EMT can proceed in the absence of cell division, and it also occurs normally in htl mutants. However, in stg; htl double mutants the EMT is significantly delayed [32]. How cell division contributes is not clear, but one possibility is that the cell's cortical tension increases during mitosis due to the RhoGEF Pbl. During cytokinesis, Pbl activates Rho1 at the cytokinetic furrow driving the actin-myosin contraction. In pbl mutants, in addition to cytokinesis failure, mesodermal cells are less rounded/dissociated, suggesting that Pbl may also contribute to Rho1-dependent actin-myosin contractility throughout the cortex [34].
Rounding of cells undergoing EMT is also a feature of gastrulating cells in the mouse primitive streak [35] and in the zebrafish neural crest EMT, where a Rho-kinase/myosin II-dependent blebbing behavior has been described [36]. This type of blebbing/ameoboid behavior is also a mode of migration employed by cancer cells and is indicative of high levels of Rho1 contractility [4]. Finally, Rho1-dependent constriction is also a mechanism by which epithelial cells can extrude other cells due to aberrant gene expression, or overcrowding ([37] and see below). Thus activation of Rho contractility pathways may be an important conserved feature of EMT.
Another finding from the cadherin-switching study was that higher levels of E-Cad inhibited activation of the WNT pathway. E-Cad and WNT signaling are intimately linked due to the dual roles of bCatenin (βCat) as a component of the adherens junction (AJ), and as a transcription co-factor for the WNT pathway. Excess E-Cad, therefore, can potentially inhibit WNT pathway activation by acting as a sink for βCat. Thus, part of the function of downregulation of E-Cad may be to potentiate the WNT pathway. The links between the WNT pathway and cancer are extensive [38], and changes in βCat localisation from the cortex to the nucleus, are a common feature of the metastatic tumor-host interface [28].
The second recent insight from this system, which has important implications for metastasis, is that Snail, traditionally thought of as a transcriptional repressor, can also directly bind, and help activate, mesodermal genes in cooperation with Twist, such as htl and N-Cad [39]. Snail and Twist binding sites were often closely associated, and approximately half of the genes bound by Snail were downregulated in snail mutants. In vitro tests showed that although Snail could not activate transcription itself, it potentiated activation by Twist. Intriguingly the authors also identified a binding motif associated with these positive enhancer elements - but the identity of the transcription factor involved is not yet known. In vertebrates, similar examples are emerging in which Snail/Slug factors positively regulate factors that promote EMT. For example Snail can activate transcription of the EMT-inducing transcription factor ZNF281 [40], and WNT target genes independently of its repressor functionality [41], while Slug can activate expression of the EMT factor ZEB1 [42]. In mice, Snai1 activates MMP15, an important factor in invasiveness [43].
Taken together the results suggest that our " canonical" views of the role Snail-family transcription factors in EMT, and the loss E-Cad, may need refinement. In the Drosophila mesoderm, levels of E-Cad are not crucial, and Snail clearly plays a broader role. Given the key role that Twist, Snail, and the FGFR and Rho signaling pathways are known to play in cancer, the Drosophila mesoderm will remain an important model system providing insight into fundamental mechanisms of metastasis, and no doubt will also continue to challenge established models.
The second EMT occurs ~ 1.5 hrs later with the formation of the endoderm. The Drosophila endoderm (or midgut) forms from two primordia at opposite poles of the embryo, which undergo an EMT, and then migrate towards each other along a cellular substrate, the visceral mesoderm (Figure 1C), and eventually undergo an MET to form the midgut epithelium.
Recently, the molecular basis for the EMT of the posterior midgut rudiment has been described. In this case the EMT does not involve repression of E-Cad, but rather the loss of apico-basal polarity. The driver of the process is the GATA-factor, Serpent, which represses the key apical polarity determinant crumbs [44]. This leads to loss of apico-basal polarity and delocalization of E-Cad around the cell membranes of the midgut cells. This mechanism represents a new paradigm for EMT that is likely to be conserved in vertebrates. Loss of apico-basal polarity has been strongly linked to cancer [45,46,47]. In addition, two human orthologs of Serpent, hGATA-4 and hGATA-6, are expressed in gut epithelial tissue [48,49], and, as in Drosophila, hGATA-6 transcriptionally represses Crumbs2, but not Epithelial Cadherin. Overexpression of hGATA-6 is also found in cancer cells [50,51,52], and can induce EMT in MDCK cells in vitro [44].
The subsequent migration event is dependent upon integrins, which are expressed by both the migrating midgut cells and the visceral mesodermal cells that they use as a substrate, and upon the integrin ligand Laminin, which lies at the interface between these two tissues [53,54,55,56]. Recent results show migration also requires the axon-guidance receptor Frazzled, which is expressed in midgut cells and responds to Netrins emanating from the visceral mesoderm [57]. As in the mesoderm, a feature of the midgut system is the continued expression of E-Cad during migration, with cell-cell spot adherens junctions existing between midgut cells [58]. The expression of E-Cad may be particularly important in the midgut since migration is followed by a MET. Our understanding of the molecular basis for this MET is rudimentary, but the formation of a columnar monolayer is disrupted by loss of either E-Cad or Laminin [59,60]. The Netrin/Frazzled pathway is also important. In embryos lacking netrins, midgut cells fail to form a columnar monolayer and apico-basal markers such as Filamin-1 and E-Cad, and the basally polarised receptor Frazzled, are all mislocalised [57]. Understanding how the Netrin and Integrin molecular pathways interact during both the migration and MET events are important future goals. Since the midgut system represents one of the few well characterized, developmental events in which an EMT is followed by a migration and MET event, it is likely to grow in importance as a model system for metastasis.
The third well-characterized EMT event, which occurs at the onset of metamorphosis, was discovered relatively recently. In 2004, Pastor-Pareja et al. [61]showed that an EMT-like event takes place during the eversion of the wing imaginal disc. This is an important model for metastasis since, unlike the mesoderm and endoderm system, it involves basement membrane (BM) degradation and the invasion of another tissue.
Imaginal discs are epithelial sacs that proliferate and are patterned during larval development, and finally, during metamorphosis, evert, migrate, and fuse with other discs to eventually generate a continuous adult epidermis. During eversion the peripodial epithelial cells (Figure 1E) undergo a partial EMT in which their AJs are disrupted, and the cells become motile and invasive. They break through the BM lying between them and the epidermis, invade the epidermal layer, and then undergo an epithelial sheet migration over the epidermis. The molecular control of this differs again from the mesodermal and endodermal EMTs. It is mediated by two pathways that appear to act in parallel: the Jun-kinase (JNK) pathway and a novel EMT pathway involving the axonal chemo-attractant Netrin.
The JNK pathway has long been associated with the processes of eversion and thorax closure and affects all aspects of the process [61,62]. The JNK pathway is activated downstream of Src family kinases [63] and the PVR receptor which appears to act through Crk, Mbc, ELMO, Rac and Cdc42 [64]. JNK activation leads to delocalization of cell-cell junction proteins, activation of cell motility and expression of the matrix metalloproteinases, MMP1 and MMP2, which degrade the BM [61,65]. Following the epithelial dissociation and BM breakdown, peripodial cells must invade the epidermis and undergo an epithelial sheet migration event. This process involves the JNK and TGFb pathways [62] and is likely to also involve Integrins since integrins are known to be required for the closely related process of embryonic dorsal closure [66], and RNAi knockdown of the aPS3 subunit scab generates thoracic clefts (R. Manhire-Heath and M. J. Murray, unpublished observations). In flies, activation of the JNK pathway appears to be a central feature of epithelial cells becoming invasive, both during normal events like wing eversion, and in situations where genetic changes induce loss of epithelial integrity (see below). There are also extensive links between JNK activation and metastasis in humans [67].
In a recently discovered pathway, which appears to act in parallel, expression of the axonal chemo-attractant NetA promotes ZA breakdown in the peripodial epithelium, via degradation of its receptor Frazzled (Fra) [68]. Fra plays an opposing role in this process. Overexpression of fra phenocopies eversion defects associated with loss of netA, while fra-RNAi can rescue netA-RNAi eversion failure, and can accelerate epithelial dissociation in vitro. Exactly how Fra opposes the dissociation is not clear but it appears to act through the ERM family protein Moesin (Moe). Moe becomes phosphorylated in response to increased Fra levels and is required for netA-RNAi eversion failure. fra and moe have both previously been shown to be required for epithelial integrity (see below) [69,70].
This finding that Netrins can regulate an EMT-like event is of interest since vertebrate Netrins and their receptors are already strongly associated with metastasis. In vertebrates there are two orthologs to Fra, Deleted in Colorectal Carcinoma (DCC) and Neogenin1. DCC can suppress metastasis by acting as a " dependence receptor" for its trophic ligand Netrin-1 [71]. Similarly, overexpression of Netrin-1, which can protect cells from apoptosis, has been observed in metastatic breast cancers [72] and ovarian cancers [73], and can promote the formation of adenocarcinomas in the mouse gut [74]. Netrin-1 and DCC can also regulate cell migration and epithelial plasticity in development [75], and Netrin-1 can increase the invasiveness of cancer cells in vivo and in vitro [76,77,78], and has been implicated in an EMT-like event in mice [79]. Conversely, DCC can inhibit an induced EMT in vitro apparently by promoting cell adhesion via ERM-M family proteins [80], and can also inhibit the invasiveness of cancer cells [78]. Finally, given the role of Fra in inhibiting epithelial dissociation and promoting the midgut MET it is worth noting that Neogenin is required to maintain cell polarity and epithelial structure in the neural tube [81].
An important question for the future is how the JNK and Netrin pathways converge on bringing about the EMT.
The fourth developmental event occurs in the developing egg-chamber. Here, a small cluster of cells delaminate from the follicular epithelium and undergo a unique, stereotyped, collective migration towards the oocyte (Figure 1G). This system, with its accessibility to live imaging, and ability to precisely manipulate gene expression within the cluster, has provided a wealth of information concerning both the delamination and collective migration. Since these events have recently been comprehensively reviewed [12] the description here will be brief, and focused on the delamination event.
The process begins when two follicle cells at the anterior pole of the egg chamber become specified as " polar cells" and secrete the cytokine Unpaired (Upd), an ortholog to vertebrate Interleukin-6. Neighboring follicle cells receive this signal through the Domeless receptor (a gp130-like cytokine receptor) leading to activation of a JAK/STAT pathway and expression of several target genes. Of these, one of the most important is Slow Border Cells (Slbo), an ortholog of vertebrate C/EBP. Slbo is essential for the delamination and subsequent migration of the border cell cluster.
At the time of delamination the border cell cluster extend a long protrusion in the direction of future movement, called the " long cellular extension" (LCE), which is dependent upon the receipt of the graded directional cue of the growth factors, and upon the Cadherin-based adhesion between the LCE and the nurse cells through which the cluster migrates [82]. The delamination of the cluster is an active process that requires actin-myosin contractility, with Par-1 promoting myosin II contractility in the rear of the border cell cluster by phosphorylating and inhibiting Myosin Phosphatase [82,83].
The delamination process also involves the Notch pathway. Notch activation is refined to the border cells at the time of delamination, and is required for their migration [84], but also for the ability of border cells to detach from the follicular epithelium [85]. The precise timing of delamination is controlled by the activation of the Ecdysone steroid hormone pathway via EcR and Ultraspiracle, together with their co-activator Taiman. An initial imbalance in Ecd signaling in border cells becomes amplified by feedback between the JAK/STAT and EcR pathways through the BTB protein Abrupt, eventually leading to the detachment of the cluster. See reference [12] for details.
Each of these molecular factors controlling border cell delamination is implicated in human metastasis. Firstly, the closest ortholog of Upd, Interleukin-6, is strongly associated with metastasis, as is the JAK/STAT pathway [86,87]. The vertebrate orthologue of Slbo, C/EBP, is elevated in carcinoma, and promotes VEGF3 and VEGFR3 expression, which increase lymphangiogenesis and pulmonary metastases [88]. Interestingly, in this system there is also an intimate link between C/EBP-d and hypoxia, which may be partly conserved in flies. Hypoxia induces C/EBP-d expression and C/EBP-d regulates HIF-1a expression. Blocking HIF-1α activity blocked CEBP-d-induced VEGF-C. In flies, the migration of the border cells is responsive to both the levels of oxygen, and levels of the Drosophila hypoxia-inducible factor HIF1a/Sim. Moreover, cells mutant for HIF1α have reduced levels of Slbo [89]. The Tai orthologue in humans AIB1 (Amplified In Breast cancer 1) is also amplified in several cancers [90]. Finally, although the mechanism by which Notch promotes border cell delamination is not known, in vertebrates Notch signaling can repress matrix adhesion genes [91].
Thus, the border cell delamination event is again complementary to the other three scenarios in that it involves a different set of genetic regulators, all of which are important in understanding human metastasis.
While normal developmental EMTs provide great insight into metastatic processes, one can also induce metastatic behavior via genetic manipulations. The ability to generate cells with complex genotypes in a normal, in vivo environment, and track those cells with live markers like GFP is an extremely powerful tool for uncovering basic principles underlying metastasis. The fact that the experiments are done in vivo is very important since the response of such cells is dependent upon the microenvironment that surrounds them, and can be modulated by system wide responses such as the innate immune system.
Although epithelia are sometimes thought of as stationary cells in a relatively inert 2D sheet, live imaging shows us that epithelial cells are quite dynamic and undergo rapid remodeling of their connections with neighboring cells. Epithelial cells must maintain homeostasis, so mechanisms exist by which aberrant cells can be removed when necessary. In terms of metastasis, one of the most common ways that an epithelial cell can lose its place in an epithelium is by loss of polarity. However, there are many other examples in Drosophila, where cells that are genetically different from their neighbors are expelled from the main epithelium. For example, expression of oncogenic RasV12 [92], loss of the Polycomb Group gene polyhomeotic [93], and loss of Dpp signaling [94] all lead to groups of epithelial cells detaching from the primary epithelium to form cysts (Figure 2B). In fact, mechanisms exist to extrude even wild type cells if overcrowded [95].
In epithelial cells, polarity is actively maintained by a number of complexes that define membrane compartments in the apical-basal axis via mutually antagonistic interactions [96]. An important complex in the discussions to follow is the basolateral Lgl/Dlgl/Scrib, complex which is essential for epithelial integrity [97]. Mutant clones for genes like scrib lose their columnar, mono-layered arrangement and become multilayered and rounded [98]. Crucially, they also activate the JNK pathway which leads to apoptosis and removal from the tissue. Elimination of cells also involves activation of a non-apoptotic JNK response in neighboring cells involving the Pvr/ELMO-Mbc pathway, which leads to phagocytic engulfment [99]. JNK activation leads not only to apoptosis, however, but to invasive behavior through expression of target genes such as mmp1 [65,100], which mediates BM degradation, and the actin binding proteins, cheerio (i.e. Filamin-1) [101] and chickadee (Profilin) [102], which promote motility.
In another example where loss of polarity led to JNK activation and apoptosis, Dekanty et al. [103] looked at the effects of inducing chromosomal instability (CIN) through manipulation of several cell cycle related genes. As with scrib mutant cells, CIN cells lost apico-basal polarity, delaminated from the epithelium and activated the JNK pathway leading to apoptosis and upregulation of MMP1 and Wg. How CIN resulted in loss of polarity was not explored but it was speculated that general stress associated with aneuploidy-induced protein imbalances might drive this process.
Similar results have been shown for three other genes: moesin (moe), the sole Drosophila ERM (ezrin/radixin/moesin) gene [69], slik, the Sterile-20 kinase [104], and fra [70]. Loss of moe disrupts epithelial integrity leading to mutant cells delaminating from the wing disc epithelium and becoming invasive (Figure 2C) [69]. This process is strongly inhibited by reduction of Rho1, and can be phenocopied by activated Rho1, suggesting that Moe's primary role in epithelia is to inhibit Rho1. A likely mechanism for this has recently been reported in which Moesin recruits the RhoGAP Conundrum to the plasma membrane [105]. The Sterile-20 kinase Slik appears to act upstream of Moesin in maintaining epithelial integrity [104]. slik mutant cells exhibit the same types of phenotypes as moe mutants such as loss of polarity, delamination, apoptosis and invasive behavior. Slik was shown to phosphorylate Moesin, and slik phenotypes could be greatly rescued by either expression of an active form of Moesin, or by loss of Rho1, consistent with the results for moe. Similarly, fra mutant clones become invasive and migratory, activate ERK and JNK pathways and MMP1 expression, and invasion can be suppressed by dominant negative RhoN19 [70].
How then might Rho1 activity lead cells to leave the epithelium? As previously mentioned several developmental EMT events involve cells rounding up in a Rho1 dependent manner, but another possibility is via the JNK pathway. It has been known for some time that several Rho-family GTPases can activate the JNK pathway, including Rac1 and Cdc42, and Rho1 [106,107]. In the case of Rho1, two potential mechanisms have been reported. Firstly, it has been shown that Rho1 can directly interact with the JNK Kinase Kinase Slipper, and, consistent with this, increases in cortical Rho1 associated with loss of moesin, can recruit Slipper to the membrane [108]. An alternative pathway involving a RhoGEF2/Rho1/Rok/myosin II pathway has also been reported, though the mechanism by which myosin II leads to JNK activation remains to be established [109].
Another pathway to JNK activation and invasion is through the Src family kinases (SFKs). For example when Csk, a negative regulator of Src, is knocked down by expression of Csk-IR (i.e. an inverted repeat construct) delamination occurs (Figure 2E). Csk-IR cells delaminate and undergo JNK-dependent migratory behavior, BM breakdown and apoptosis [110]. As with other systems the JNK activation, invasion and migration is dependent upon Rho1. Invasion is also dependent upon MMP1, and p120ctn, a well-known SFK target. Surprisingly, invasion is inhibited by reduction in E-Cad, suggesting that delamination is an active process that involves AJ adhesion and remodelling. Rudrapatna et al. [111] have also found that the Src activation of JNK is via Rho1 and, is dependent upon the Actin Regulatory Proteins Cofilin and Enabled. Thus, cytoskeletal regulators appear not only to act downstream of JNK during invasion but, like myosin II, are able to activate the JNK pathway as well, though again the mechanism is not clear.
SFKs may not always act through Rho1 however. Expression of the oncogene Abelson kinase, in the wing stripe assay causes a similar phenotype to Csk-RNAi, with cell delamination, activation of JNK and expression of MMP1 [112]. Abl appears to act downstream of SFKs, since the effects of Csk-RNAi are inhibited by Abl-RNAi. Abl could also activate SFKs indicating the potential for a positive feedback loop. However, in contrast to Rudrapatna et al. [111] the downstream effects of Abl, including JNK activation, were dependent, not upon Rho1, but on the three Rac GTPases, suggesting multiple pathways from SFKs to JNK activation exist.
A potential upstream regulator of Csk has also been reported. Knockdown of the Histone Deacetylase, Sin3a causes excessive delamination, upregulation of N-Cad, MMP1, and degradation of the BM, particularly when combined with overexpression of the oncogene RetMEN2 [113]. Using Histone Deacetylation marks, CHIP-seq and RTPCR the authors found Sin3A, positively regulates Csk (and interestingly, fra) while negatively regulating RhoGEF2 and Rho1, consistent with their respective roles in regulating epithelial stability.
Thus the response of cells to various stresses and loss of polarity is the activation of the JNK pathway, which promotes both apoptosis and invasive behaviors. Consequently, when apoptosis is prevented by expression of oncogenes the result is highly metastatic tumors.
For example, Brumby et al. [114]found that while scrib−/− clones underwent JNK-dependent apoptosis (Figure 3D), co-expression of the activated oncogenes, NotchACT or RasV12, resulted in massive overgrowth and fusion of the eye-antennal discs with each other and with neighboring tissue, suggesting invasive behavior (Figure 3F). Further screening for genetic interactors in this process determined that the activation of JNK was likely to be via a RhoGEF pathway [98].
Similarly, Pagliarini et al. [115]induced RasV12 tumors in the eye-antennal disc, and then screened for mutations that could mediate metastatic transformation. Loss of scrib created highly metastatic tumors that induced BM breakdown and migrated down the nerve cord, exhibiting protrusive leading edges (Figure 3B). Similar results could be obtained with other polarity genes such as lgl, dlg, sdt, baz, and cdc42, and in each case the invasive behavior was due to JNK activation [116].
Further screening identified Src42A as an essential mediator acting downstream of the RasV12/lgl−/− tumor cascade. Src42A-RNAi could block invasion and JNK activation of RasV12/lgl−/− tumors, and the posterior delamination/migration of ptc > lgl-IR cells in the wing disc [117]. In this case, Src42A has been shown to act through the Bendless/dUEV1a ubiquitin-conjugating E2 enzyme complex and the E3 ligase dTRAF2, in activating JNK. How the Rho GTPases and ARP pathways interact with these upstream components of the JNK pathway is an important question for future studies to address.
Similar results are obtained when apoptosis is inhibited by other methods. In the previous example of CIN cells [103], expression of the caspase-inhibitor p35, led to tumor cells that when injected into host abdomens could metastasize to ovaries (Figure 3C). Similarly, Rudrapatna et al. [118] showed that by precisely controlling the level of caspase activity one could prevent JNK-dependent apoptosis, while still allowing the JNK invasive pathway. This result may explain why human cancer progression is often associated with increased levels of effector caspases [119].
Strikingly, it has also been shown that loss of scrib does not actually need to be in the same cells that are overexpressing the oncogene RasV12. When clones of scrib−/− cells are adjacent to RasV12 expressing cells the same invasive tumors result (Figure 3G) [120]. The mechanism involves JNK pathway activation, which occurs in scrib−/− cells, propagating to the RasV12 cells, via some as yet unknown mechanism. This study also highlighted the importance of the cytokine Upd. JNK activation in both the scrib−/− cells and the RasV12 cells increased expression of Upd and this was necessary for invasion. This study also placed the JAK/STAT pathway downstream of JNK, in that BskDN was able to prevent RasV12/scrib−/− tumors from invading, but not RasV12/Upd tumors.
A separate study has confirmed the synergistic interaction between Ras and JAK/STAT pathways. Herranz et al. [121]found that when the EGFR receptor, which acts upstream of Ras, is overexpressed, coexpression of the miRNA bantam produced massive neoplastic tumors with loss of apico-basal polarity, and upregulation of mmp1 and snail. Further study determined that bantam was repressing the JAK/STAT repressor Socs36E, and knocking down socs36E in the EGFR overexpression background also produced neoplastic, metastatic tumors.
Drosophila is also helping us understand the complex relationship between tumor cells and inflammation. Tumor-associated inflammation has long been known to both facilitate and inhibit tumor growth, invasion and metastasis [122,123,124]. In Drosophila, the cellular part of the innate immune system consists blood cells called hemocytes, which circulate in the hemolymph that bathes the larval organs. Recent work shows that hemocytes are attracted to sites of tissue damage, and to the scrib−/− and RasV12/scrib−/− tumors due to the BM breakdown on their basal surface, and can inhibit the growth of scrib−/− tumors (Figure 3H) [125]. Furthermore, RasV12/scrib−/− tumors were shown to upregulate the cytokines Upd, Upd2 and Upd3, which in turn led to increased JAK/STAT signaling and Upd3 expression in hemocytes and the fat body cells, creating a system wide increase in cytokines, and in the number of hemocytes (Figure 3I) [125]. Cordero et al. [126] have since shown that Tumor-Associated Hemocytes (TAHs) express Eiger, the sole Drosophila ortholog of Tumor Necrosis Factor (TNF), and this is necessary for the removal of lgl−/− tumors. In the case of the RasV12/scrib−/− tumors, however, the activation of JNK led to invasiveness—providing a clear example in Drosophila of the immune system promoting metastatic behavior.
The effects of several other oncogenes that are often upregulated in cancers have also been tested by overexpression in imaginal disc tissue. For example, overexpression of the transcription factors TBX2 and TBX3 is a common feature of several human cancers. Shen et al., [127]found that overexpression of the Drosophila ortholog, optomotor-blind (omb), or indeed the human gene TBX2, caused downregulation of E-Cad, induction of cell motility, which allowed cells to disperse through the wing disc epithelium—without disruption of the BM. The centrosomal kinase, Nek2 is also highly expressed in cancer and given its role in mitosis, had been thought to contribute to late stage cancers through promoting CIN. Studies of the fly Nek2, however, suggest an earlier role [128]. Nek2 cooperates with the oncogenic RTK RetMEN2B in promoting dissemination in the wing stripe assay, and increases dissemination of RasV12/Csk−/− tumor cells in the eye-antennal discs. Also, when mutant tissue is injected into the notum of an adult fly, distant metastatic tumors are seen in other parts of the animal in the case of Nek2/RasV12/Csk−/− cells but not for Nek2 or RasV12/Csk−/− cells [128].
Finally activation of the Notch pathway, in conjunction with other factors, such as loss of scrib, expression of the epigenetic regulators Lola and Pipsqueak, Atonal, Mef2 and others, can be a potent trigger for metastasis. For a recent and extensive review on Notch pathways to metastasis in flies see [129].
What might the future hold for Drosophila research into metastasis? Analysis of normal developmental EMT/MET events will no doubt continue since there clearly remains much to be discovered. For example, although the mesodermal EMT was first described over 25 years ago, the molecular factors that drive the loss of epithelial structure are still not clear. In the case of the endoderm, the molecular mechanisms acting downstream of Integrins and Frazzled, to drive the MET, remain unexplored.
In the case of induced metastatic behavior, future research avenues are really limited only by the imagination, and will undoubtedly grow in complexity and sophistication. For example, the ability to generate sister cells with different genotypes, as was done for RasV12 and scrib−/− [120], should allow further exploration of models in which a mix of cell types (e.g. " EMT" and " non-EMT" cells) promote metastasis [7]. Methods for manipulating and assaying gene expression will continue to grow, as each year brings powerful new tools such as CrispR [130], genome-wide libraries of GAL4 drivers [131], and methods for in vivo transcriptional profiling [132].
One aspect of metastasis that has yet to receive much attention is the way disseminated cells can grow into a secondary tumor. Given the importance of MET to metastasis, of particular interest will be those that exhibit some epithelial characteristics. While tumors caused by loss of polarity factors like scrib would not be expected to show any epithelial structure [97] others might. For example, ectopic expression of Delta in the eye generates secondary growths that appear structured and contain differentiated cell types [133]. Since such tumors can apparently attract tracheal branches [129], they may also provide a useful model for tumor neovascularisation. Indeed, the mechanisms of morphogenesis in the Drosophila tracheal system are already providing key insights into tumor angiogenesis [18]. Fundamental principles, such as Notch-based selection of leader cells, and partial EMT in response to FGF ligands, closely parallel the mechanisms of branching of blood vessels.
Another likely growth area will be testing the effect of therapeutic drugs on metastasis. The combination of drug treatments and genetic analysis in a whole-animal context is particularly powerful. For example, Willoughby et al. [134] used the RasV12/scrib−/− model to test the bioavailability, efficacy and toxicity of drugs such as MEK inhibitors to inhibit metastasis and tumor growth. In a screen of 2000 compounds the glutamine analogue, acivicin, was shown to reduce tumor overgrowth, and subsequent genetic analysis revealed CTP synthase to be its likely target. Similarly, in the MEN2 model in which the activated Ret receptor is expressed, researchers showed that the drug Vandetanib had high efficacy but low toxicity [135]. In subsequent experiments the efficacy and toxicity of various Ret-inhibitors was compared, and the importance of coordinated inhibition of other signaling pathways such as Src and Raf was demonstrated [136]. Flies may even become a standard workhorse in personalized medicine. The ability to firstly model a primary cancer-causing oncogene, and then analyse the efficacy of drugs and the consequences of secondary mutations may provide a way of identifying functionally important genomic changes identified by genomic sequencing of tumors [137].
For those that do not work with flies it may not be obvious what they have to tell us about human processes such as metastasis. However, as the examples in this review demonstrate, there exists an extraordinary level of conservation, both of the molecular pathways, and of the cellular processes that they control. This, together with the extensive array of genetic tools, means that studies in the fly can elucidate important underlying principles that are directly relevant to human cancer. While one will always be able to find differences between flies and humans, recognizing and exploiting the many similarities, can bring substantial rewards.
I apologize to all the colleagues whose studies could not be covered due to space limitations and thank S. Golenkina and H. Weerasinghe for critical reading of the manuscript, and the reviewers for helpful comments and suggestions.
Author declares no conflicts of interest in this paper.
[1] |
J. Juhász, T. Bányai, Last mile logistics: an integrated view, IOP Conf. Ser.: Mater. Sci. Eng., 448 (2018), 012026. https://doi.org/10.1088/1757-899X/448/1/012026 doi: 10.1088/1757-899X/448/1/012026
![]() |
[2] |
C. Liu, Z. Wang, Z. Liu, K. Huang, Multi-Agent reinforcement learning framework for addressing Demand-Supply imbalance of Shared Autonomous Electric Vehicle, Transp. Res. Part E Logist. Transp. Rev., 197 (2025), 104062. https://doi.org/10.1016/j.tre.2025.104062 doi: 10.1016/j.tre.2025.104062
![]() |
[3] |
M. R. Ibarra, J. D. M. Saphores, 1,000 HP electric drayage trucks as a substitute for new freeway lanes construction, Transp. Res. Part Policy Pract., 171 (2023), 103646. https://doi.org/10.1016/j.tra.2023.103646 doi: 10.1016/j.tra.2023.103646
![]() |
[4] |
D. Huang, J. Zhang, Z. Liu, A robust coordinated charging scheduling approach for hybrid electric bus charging systems, Transp. Res. Part Transp. Environ., 125 (2023), 103955. https://doi.org/10.1016/j.trd.2023.103955 doi: 10.1016/j.trd.2023.103955
![]() |
[5] |
Z. Liu, X. Chen, Q. Meng, I. Kim, Remote park-and-ride network equilibrium model and its applications, Transp. Res. Part B Methodol., 117 (2018), 37–62. https://doi.org/10.1016/j.trb.2018.08.004 doi: 10.1016/j.trb.2018.08.004
![]() |
[6] | J. R. Montoya-Torres, J. L. Franco, S. N. Isaza, H. F. Jiménez, N. Herazo-Padilla, A literature review on the vehicle routing problem with multiple depots, Comput. Ind. Eng., 79 (2015), 115–129. |
[7] |
C. C. Murray, A. G. Chu, The flying sidekick traveling salesman problem: Optimization of drone-assisted parcel delivery, Transp. Res. Part C Emerg. Technol., 54 (2015), 86–109. https://doi.org/10.1016/j.trc.2015.03.005 doi: 10.1016/j.trc.2015.03.005
![]() |
[8] |
D. Reyes, M. Savelsbergh, A. Toriello, Vehicle routing with roaming delivery locations, Transp. Res. Part C Emerg. Technol., 80 (2017), 71–91. https://doi.org/10.1016/j.trc.2017.04.003 doi: 10.1016/j.trc.2017.04.003
![]() |
[9] |
Y. Wang, Y. Wei, X. Wang, Z. Wang, H. Wang, A clustering-based extended genetic algorithm for the multidepot vehicle routing problem with time windows and three-dimensional loading constraints, Appl. Soft Comput., 133 (2023), 109922. https://doi.org/10.1016/j.asoc.2022.109922 doi: 10.1016/j.asoc.2022.109922
![]() |
[10] |
D. Huang, Z. Liu, P. Liu, J. Chen, Optimal transit fare and service frequency of a nonlinear origin-destination based fare structure, Transp. Res. Part E Logist. Transp. Rev., 96 (2016), 1–19. https://doi.org/10.1016/j.tre.2016.10.004 doi: 10.1016/j.tre.2016.10.004
![]() |
[11] |
Z. Jia, D. Huang, Z. Liu, Z. Hu, R. Liu, W. Yu, Multi-objective optimization for the sightseeing bus problem: Trade-off between tourists and operator, Expert Syst. Appl., 269 (2025), 126341. https://doi.org/10.1016/j.eswa.2024.126341 doi: 10.1016/j.eswa.2024.126341
![]() |
[12] |
Y. Liu, Z. Liu, R. Jia, DeepPF: A deep learning based architecture for metro passenger flow prediction, Transp. Res. Part C Emerg. Technol., 101 (2019), 18–34. https://doi.org/10.1016/j.trc.2019.01.027 doi: 10.1016/j.trc.2019.01.027
![]() |
[13] |
X. Chen, Z. Liu, K. Zhang, Z. Wang, A parallel computing approach to solve traffic assignment using path-based gradient projection algorithm, Transp. Res. Part C Emerg. Technol., 120 (2020), 102809. https://doi.org/10.1016/j.trc.2020.102809 doi: 10.1016/j.trc.2020.102809
![]() |
[14] |
Q. Cheng, Z. Wang, Y. Lin, Z. Liu, Capturing traffic state variation process: An analytical modeling approach, Transp. Res. Part E Logist. Transp. Rev., 198 (2025), 104119. https://doi.org/10.1016/j.tre.2025.104119 doi: 10.1016/j.tre.2025.104119
![]() |
[15] | J. C. Thill, T. H. D. Dao, Y. Zhou, Traveling in the three-dimensional city: applications in route planning, accessibility assessment, location analysis and beyond, J. Transp. Geogr., 19 (2011), 405–421. https://doi.org/10.1016/j.jtrangeo.2010.11.007 |
[16] | T. Bektas, The multiple traveling salesman problem: an overview of formulations and solution procedures, omega, 34 (2006), 209–219. |
[17] | B. Eksioglu, A. V. Vural, A. Reisman, The vehicle routing problem: A taxonomic review, Comput. Ind. Eng., 57 (2009), 1472–1483. |
[18] | J. Mańdziuk, C. Nejman, Uct-based approach to capacitated vehicle routing problem, in Artificial Intelligence and Soft Computing: 14th International Conference, Proceedings, Part II 14. Springer International Publishing, (2015), 679–690. https://doi.org/10.1007/978-3-319-19369-4_60 |
[19] |
G. Kim, Y. S. Ong, C. K. Heng, P. S. Tan, N. A. Zhang, City Vehicle Routing Problem (City VRP): A review, IEEE Trans. Intell. Transp. Syst., 16 (2015), 1654–1666. https://doi.org/10.1109/TITS.2015.2395536 doi: 10.1109/TITS.2015.2395536
![]() |
[20] | B. L. Golden, Vehicle Routing Problems: Formulations and Heuristic Solution Techniques. Massachusetts Institute of Technology, Operations Research Center, 1975. |
[21] | H. Quak, M. B. de Koster, Delivering goods in urban areas: how to deal with urban policy restrictions and the environment, Transp. Sci., 43 (2009), 211–227. |
[22] |
S. W. Lin, V. F. Yu, S. Y. Chou, A note on the truck and trailer routing problem, Expert Syst. Appl., 37 (2010), 899–903. https://doi.org/10.1016/j.eswa.2009.06.077 doi: 10.1016/j.eswa.2009.06.077
![]() |
[23] | M. M. Solomon, Algorithms for the vehicle routing and scheduling problems with time window constraints, Oper. Res., 35 (1987), 254–265. |
[24] | N. Balakrishnan, Simple heuristics for the vehicle routeing problem with soft time windows, J. Oper. Res. Soc., 44 (1993), 279–287. |
[25] |
M. Gendreau, F. Guertin, J. Y. Potvin, É. Taillard, Parallel tabu search for real-time vehicle routing and dispatching, Transp. Sci., 1999. https://doi.org/10.1287/trsc.33.4.381 doi: 10.1287/trsc.33.4.381
![]() |
[26] |
H. Hashimoto, T. Ibaraki, S. Imahori, M. Yagiura, The vehicle routing problem with flexible time windows and traveling times, Discrete Appl. Math., 154 (2006), 2271–2290. https://doi.org/10.1016/j.dam.2006.04.009 doi: 10.1016/j.dam.2006.04.009
![]() |
[27] | E. Angelelli, R. Mansini, The vehicle routing problem with time windows and simultaneous pick-up and delivery, in Quantitative Approaches to Distribution Logistics and Supply Chain Management, Springer, (2002), 249–267. |
[28] | M. Goetschalckx, C. Jacobs-Blecha, The vehicle routing problem with backhauls, Eur. J. Oper. Res., 42 (1989), 39–51. |
[29] | A. M. Altabeeb, A. M. Mohsen, A. Ghallab, An improved hybrid firefly algorithm for capacitated vehicle routing problem, Appl. Soft Comput., 84 (2019), 105728. |
[30] | L. M. Gambardella, É. Taillard, G. Agazzi, MACS-VRPTW: A multiple ant colony system for vehicle routing problems with time windows, Istituto Dalle Molle Di Studi Sull Intelligenza Artificiale, 1999. |
[31] |
Y. Wang, L. Wang, Z. Peng, G. Chen, Z. Cai, L. Xing, A multi ant system based hybrid heuristic algorithm for vehicle routing problem with service time customization, Swarm Evol. Comput., 50 (2019), 100563. https://doi.org/10.1016/j.swevo.2019.100563 doi: 10.1016/j.swevo.2019.100563
![]() |
[32] |
H. Zhang, Q. Zhang, L. Ma, Z. Zhang, Y. Liu, A hybrid ant colony optimization algorithm for a multi-objective vehicle routing problem with flexible time windows, Inf. Sci., 490 (2019), 166–190. https://doi.org/10.1016/j.ins.2019.03.070 doi: 10.1016/j.ins.2019.03.070
![]() |
[33] |
X. Zheng, F. Gao, X. Tong, Research on green vehicle path planning of AGVs with simultaneous pickup and delivery in intelligent workshop, Symmetry, 15 (2023), https://doi.org/10.3390/sym15081505 doi: 10.3390/sym15081505
![]() |
[34] | A. Goel, V. Gruhn, A general vehicle routing problem, Eur. J. Oper. Res., 191 (2008), 650–660. |
[35] |
Z. Gu, X. Yang, Q. Zhang, W. Yu, Z. Liu, TERL: Two-stage ensemble reinforcement learning paradigm for large-scale decentralized decision making in transportation simulation, IEEE Trans. Knowl. Data Eng., 35 (2023), 13043–13054. https://doi.org/10.1109/TKDE.2023.3272688 doi: 10.1109/TKDE.2023.3272688
![]() |
[36] |
A. H. Golsefidi, F. B. Hüttel, I. Peled, S. Samaranayake, F. C. Pereira, A joint machine learning and optimization approach for incremental expansion of electric vehicle charging infrastructure, Transp. Res. Part Policy Pract., 178 (2023), 103863. https://doi.org/10.1016/j.tra.2023.103863 doi: 10.1016/j.tra.2023.103863
![]() |
[37] |
Y. Wang, S. Luo, J. Fan, L. Zhen, The multidepot vehicle routing problem with intelligent recycling prices and transportation resource sharing, Transp. Res. Part E Logist. Transp. Rev., 185 (2024), 103503. https://doi.org/10.1016/j.tre.2024.103503 doi: 10.1016/j.tre.2024.103503
![]() |
[38] |
S. Erdoğan, E. Miller-Hooks, A green vehicle routing problem, Transp. Res. Part E Logist. Transp. Rev., 48 (2012), 100–114. https://doi.org/10.1016/j.tre.2011.08.001 doi: 10.1016/j.tre.2011.08.001
![]() |
[39] |
X. Yang, Z. Liu, Q. Cheng, P. Liu, Geometry-aware car-following model construction: Theoretical modeling and empirical analysis on horizontal curves, Transp. Res. Part C Emerg. Technol., 166 (2024), 104772. https://doi.org/10.1016/j.trc.2024.104772 doi: 10.1016/j.trc.2024.104772
![]() |
[40] | Z. Wang, Y. Lin, Z. Liu, Y. Zheng, P. Liu, Q. Cheng, Traffic Dynamics Modeling with an Extended S3 Car Following Model, Social Science Research Network, Rochester, https://doi.org/10.2139/ssrn.4882338 |
1. | Sofia Golenkina, Rosemary Manhire-Heath, Michael J. Murray, 2021, Chapter 11, 978-1-0716-0778-7, 115, 10.1007/978-1-0716-0779-4_11 | |
2. | Grace Jefferies, Jason Somers, Isabelle Lohrey, Vishal Chaturvedi, Jacob Calabria, Owen J Marshall, Tony D Southall, Robert Saint, Michael J Murray, Maintenance of Cell Fate by the Polycomb Group Gene Sex Combs Extra Enables a Partial Epithelial Mesenchymal Transition inDrosophila, 2020, 10, 2160-1836, 4459, 10.1534/g3.120.401785 | |
3. | Chaitali Khan, Nasser M. Rusan, Using Drosophila to uncover the role of organismal physiology and the tumor microenvironment in cancer, 2024, 10, 24058033, 289, 10.1016/j.trecan.2024.01.007 | |
4. | Helena E. Richardson, Drosophila models of cancer, 2015, 02, 2377-1143, 097, 10.3934/genet.2015.1.97 | |
5. | Avnika Singh Anand, Kalyani Verma, Dipti N. Prasad, Ekta Kohli, The interplay of calponin, wnt signaling, and cytoskeleton protein governs transgenerational phenotypic abnormalities in drosophila exposed to zinc oxide nanoparticles, 2023, 369, 00092797, 110284, 10.1016/j.cbi.2022.110284 |
* These human orthologs were curated from Drosophila literature. All others were extracted from Ensembl Biomart. | |||
Gene symbol | Gene name | Molecular function | Human orthologues |
ab | abrupt | BTB-Zinc Finger Transcription Factor | |
Abl | Abl tyrosine kinase | Cytoplasmic tyrosine kinase | ABL1, ABL2 |
arm | armadillo | Catenin (adherens junction component) | CTNNB1 |
ban | bantam | microRNA | |
ben | bendless | Part of Ben/dUev1a E2 ubiquitin-conjugating enzyme complex | UBE2Z |
bsk | basket | JUN kinase | MAPK8, MAPK9, MAPK10 |
N-Cad | N-Cadherin | N-Cadherin | CDH2 * |
Cdc42 | Cdc42 | Rho GTPase | CDC42 |
Ced-12 | Ced-12 | PH-domain protein, complexes with DOCK180 | ELMO1, ELMO2, ELMO3 |
cher | cheerio | Filamin protein | FLNA, FLNB, FLNC |
chic | chickadee | Profilin protein | PFN1, PFN2, PFN3, PFN4 * |
conu | conundrum | Rho GAP | ARHGAP40 |
crb | crumbs | transmembrane apical polarity complex protein | CRB1, CRB2 |
Crk | Crk | SH2/SH3-containing adaptor protein | CRKL |
Csk | C-terminal Src kinase | cytoplasmic tyrosine kinase, negative regulator of Src | CSK |
cta | concertina | Gα12/13 subunit | GNA12, GNA13 |
dlg1 | discs large 1 | MAGUK scaffolding protein, part of Scrib/Dlg/Lgl complex | DLG4 |
dome | domeless | gp130-like JAK/STAT Receptor | |
dpp | decapentaplegic | TGF ligand | BMP2, BMP4 |
EcR | Ecdysone receptor | part of the EcR/Usp ecdysone receptor heterodimer | NR1H4 |
egr | eiger | Tumor Necrosis Factor | |
ena | enabled | actin-associated protein | VASP, ENL |
fog | folded gastrulation | secreted protein | |
fra | frazzled | Netrin receptor | DCC, NEO1 |
hep | hemipterous | Jun kinase kinase | MAP2K7 |
HIF-1α | Hypoxia Induced Factor 1α | Hypoxia Induced Factor | HIF-1α * |
htl | heartless | FGF Receptor | FGFR1, FGFR2, FGFR3, FGFR4 |
Jra (Jun) | Jun-related antigen | part of Jun/Fos (AP-1) transcription factor | JUN, JUNB, JUND |
Kay(Fos) | kayak | part of JUN/FOS (AP-1) transcription factor | FOS, FOSL1, FOSL2, FOSB |
l(2)gl | lethal (2) giant larvae | Scaffolding protein, part of Scrib/Dlg/Lgl complex | LLGL1, LLGL2 |
mbc | myoblast city | DOCK-family GTP Exchange Factor (GEF) | DOCK1, DOCK2, DOCK5 |
mist | mesoderm-invagination signal transducer | G-protein-coupled Receptor | |
Mmp1 | Matrix metalloproteinase 1 | Matrix Metalloproteinase | MMP19, MMP28 * |
Mmp2 | Matrix metalloproteinase 2 | Matrix Metalloproteinase | MMP1, MMP3, MMP7, MMP8, MMP10, MMP11, MMP13, MMP14, MMP15, MMP17, MMP20, MMP24, MMP25, MMP27, AP000789.1 |
Moe | Moesin | ERM-family protein, F-Actin/trans-membrane linker | EZR, MSN, RDX |
N | Notch | Notch receptor | NOTCH1, NOTCH2, NOTCH3, NOTCH4, SNED1 |
NetA | Netrin-A | Netrin, secreted chemotactic factor | NTN1, NTN3, NTN4, NTN5, NTNG1, NTNG2, LAMB3 |
NetB | Netrin-B | Netrin, secreted chemotactic factor | NTN1, NTN3, NTN4, NTN5, NTNG1, NTNG2, LAMB3 |
p120ctn | Adherens junction protein p120 | p120 Catenin (adherens junction component) | CTNND1, CTNND2, PKP1, PKP2, PKP3, PKP4, ARVCF |
par-1 | par-1 | serine/threonine kinase | MARK1, MARK2, MARK3, MARK4 |
pbl | pebble | Rho GTP Exchange Factor (RhoGEF) | ECT2 |
ph-d | polyhomeotic distal | Polycomb Group repressor complex subunit | PHC1, PHC2, PHC3 |
Pvr | PDGF- and VEGF-receptor related | PDGF/VEGF-Receptor Tyrosine Kinase | PDGFRA, PDGFRB, FLT1, FLT3, FLT4, CSF1R, KDR, KIT |
pyr (FGF8-like2) | pyramus | FGF ligand | |
Rac1 | Rac1 | Rho GTPase | RAC1, RAC2, RAC3 |
Ras85D | Ras oncogene at 85D | Ras GTPase | ERAS, KRAS, HRAS, HRAS |
Rho1 | Rho1 | Rho GTPase | RHOA, RHOB, RHOC |
RhoGEF2 | Rho guanine nucleotide exchange factor 2 | Rho GTP Exchange Factor (RhoGEF) | ARHGEF1, ARHGEF11, ARHGEF12 |
scb | scab | Integrin alpha-subunit | ITGA1, ITGA11, ITG4, ITGA2, ITGAD, ITGAL, ITGAE, ITGA9, ITGA10, ITGAX, ITGAM |
scrib | scribbled | LRR/PDZ scaffolding protein, part of Scrib/Dlg/Lgl complex | SCRIB, LRRC1 |
sdt | stardust | MAGUK family of scaffolding protein, part of Crumbs apical complex | MPP5 |
shg (E-Cad) | shotgun | Epithelial Cadherin (adherens junction component) | CDH1 * |
Sin3A | Sin3A | Sin3-family Histone Deacetylase | SIN3A, SIN3B |
slbo | slow border cells | C/EBP transcription factor | |
slik | Sterile20-like kinase | Sterile20 kinase | SLK, SLK10 |
slpr | slipper | Jun kinase kinase kinase | MAP3K9, MAP3K10, MAP3K11, RP5-862P8.2 |
sna | snail | Snail family transcription factor | SNAI1, SNAI2, SNAI3 |
Socs36E | Suppressor of cytokine signaling at 36E | cytoplasmic suppressors of JAK/STAT signaling | SOCS4, SOCS5 |
srp | serpent | GATA-factor | hGATA4, hGATA5, hGATA6 * |
T48 | Transcript 48 | membrane protein | |
tai | taiman | Steroid receptor co-activator | AIB1 * |
Tak1 | TGF-beta activated kinase 1 | Jun kinase kinase kinase | MAP3K7 |
ths (FGF8-like1) | thisbe | FGF ligand | |
Traf6 | TNF-receptor-associated factor 6 | TNF Receptor-associated factor | |
tsr | twinstar | Cofilin/Actin Depolymerising Factor | CFL1, CFL2, ADF * |
twi | twist | Twist transcription factor | TWIST1, TWIST2 |
Uev1A | Ubiquitin-conjugating enzyme variant 1A | Part of Ben/dUev1a E2 ubiquitin-conjugating enzyme complex | UBE2V1, UBE2V2 |
Upd | Unpaired | Interleukin-like JAK/STAT ligand | IL-6 * |
upd2 | unpaired 2 | Interleukin-like JAK/STAT ligand | IL-6 * |
upd3 | unpaired 3 | Interleukin-like JAK/STAT ligand | IL-6 * |
usp | ultraspiracle | part of the EcR/Usp ecdysone receptor heterodimer | RXRA, RXRB, RXRG |
wg | wingless | WNT/Wingless secreted ligand | WNT1 |
wgn | wengen | TNF Receptor | |
zip | zipper | non-muscle myosin II |
* These human orthologs were curated from Drosophila literature. All others were extracted from Ensembl Biomart. | |||
Gene symbol | Gene name | Molecular function | Human orthologues |
ab | abrupt | BTB-Zinc Finger Transcription Factor | |
Abl | Abl tyrosine kinase | Cytoplasmic tyrosine kinase | ABL1, ABL2 |
arm | armadillo | Catenin (adherens junction component) | CTNNB1 |
ban | bantam | microRNA | |
ben | bendless | Part of Ben/dUev1a E2 ubiquitin-conjugating enzyme complex | UBE2Z |
bsk | basket | JUN kinase | MAPK8, MAPK9, MAPK10 |
N-Cad | N-Cadherin | N-Cadherin | CDH2 * |
Cdc42 | Cdc42 | Rho GTPase | CDC42 |
Ced-12 | Ced-12 | PH-domain protein, complexes with DOCK180 | ELMO1, ELMO2, ELMO3 |
cher | cheerio | Filamin protein | FLNA, FLNB, FLNC |
chic | chickadee | Profilin protein | PFN1, PFN2, PFN3, PFN4 * |
conu | conundrum | Rho GAP | ARHGAP40 |
crb | crumbs | transmembrane apical polarity complex protein | CRB1, CRB2 |
Crk | Crk | SH2/SH3-containing adaptor protein | CRKL |
Csk | C-terminal Src kinase | cytoplasmic tyrosine kinase, negative regulator of Src | CSK |
cta | concertina | Gα12/13 subunit | GNA12, GNA13 |
dlg1 | discs large 1 | MAGUK scaffolding protein, part of Scrib/Dlg/Lgl complex | DLG4 |
dome | domeless | gp130-like JAK/STAT Receptor | |
dpp | decapentaplegic | TGF ligand | BMP2, BMP4 |
EcR | Ecdysone receptor | part of the EcR/Usp ecdysone receptor heterodimer | NR1H4 |
egr | eiger | Tumor Necrosis Factor | |
ena | enabled | actin-associated protein | VASP, ENL |
fog | folded gastrulation | secreted protein | |
fra | frazzled | Netrin receptor | DCC, NEO1 |
hep | hemipterous | Jun kinase kinase | MAP2K7 |
HIF-1α | Hypoxia Induced Factor 1α | Hypoxia Induced Factor | HIF-1α * |
htl | heartless | FGF Receptor | FGFR1, FGFR2, FGFR3, FGFR4 |
Jra (Jun) | Jun-related antigen | part of Jun/Fos (AP-1) transcription factor | JUN, JUNB, JUND |
Kay(Fos) | kayak | part of JUN/FOS (AP-1) transcription factor | FOS, FOSL1, FOSL2, FOSB |
l(2)gl | lethal (2) giant larvae | Scaffolding protein, part of Scrib/Dlg/Lgl complex | LLGL1, LLGL2 |
mbc | myoblast city | DOCK-family GTP Exchange Factor (GEF) | DOCK1, DOCK2, DOCK5 |
mist | mesoderm-invagination signal transducer | G-protein-coupled Receptor | |
Mmp1 | Matrix metalloproteinase 1 | Matrix Metalloproteinase | MMP19, MMP28 * |
Mmp2 | Matrix metalloproteinase 2 | Matrix Metalloproteinase | MMP1, MMP3, MMP7, MMP8, MMP10, MMP11, MMP13, MMP14, MMP15, MMP17, MMP20, MMP24, MMP25, MMP27, AP000789.1 |
Moe | Moesin | ERM-family protein, F-Actin/trans-membrane linker | EZR, MSN, RDX |
N | Notch | Notch receptor | NOTCH1, NOTCH2, NOTCH3, NOTCH4, SNED1 |
NetA | Netrin-A | Netrin, secreted chemotactic factor | NTN1, NTN3, NTN4, NTN5, NTNG1, NTNG2, LAMB3 |
NetB | Netrin-B | Netrin, secreted chemotactic factor | NTN1, NTN3, NTN4, NTN5, NTNG1, NTNG2, LAMB3 |
p120ctn | Adherens junction protein p120 | p120 Catenin (adherens junction component) | CTNND1, CTNND2, PKP1, PKP2, PKP3, PKP4, ARVCF |
par-1 | par-1 | serine/threonine kinase | MARK1, MARK2, MARK3, MARK4 |
pbl | pebble | Rho GTP Exchange Factor (RhoGEF) | ECT2 |
ph-d | polyhomeotic distal | Polycomb Group repressor complex subunit | PHC1, PHC2, PHC3 |
Pvr | PDGF- and VEGF-receptor related | PDGF/VEGF-Receptor Tyrosine Kinase | PDGFRA, PDGFRB, FLT1, FLT3, FLT4, CSF1R, KDR, KIT |
pyr (FGF8-like2) | pyramus | FGF ligand | |
Rac1 | Rac1 | Rho GTPase | RAC1, RAC2, RAC3 |
Ras85D | Ras oncogene at 85D | Ras GTPase | ERAS, KRAS, HRAS, HRAS |
Rho1 | Rho1 | Rho GTPase | RHOA, RHOB, RHOC |
RhoGEF2 | Rho guanine nucleotide exchange factor 2 | Rho GTP Exchange Factor (RhoGEF) | ARHGEF1, ARHGEF11, ARHGEF12 |
scb | scab | Integrin alpha-subunit | ITGA1, ITGA11, ITG4, ITGA2, ITGAD, ITGAL, ITGAE, ITGA9, ITGA10, ITGAX, ITGAM |
scrib | scribbled | LRR/PDZ scaffolding protein, part of Scrib/Dlg/Lgl complex | SCRIB, LRRC1 |
sdt | stardust | MAGUK family of scaffolding protein, part of Crumbs apical complex | MPP5 |
shg (E-Cad) | shotgun | Epithelial Cadherin (adherens junction component) | CDH1 * |
Sin3A | Sin3A | Sin3-family Histone Deacetylase | SIN3A, SIN3B |
slbo | slow border cells | C/EBP transcription factor | |
slik | Sterile20-like kinase | Sterile20 kinase | SLK, SLK10 |
slpr | slipper | Jun kinase kinase kinase | MAP3K9, MAP3K10, MAP3K11, RP5-862P8.2 |
sna | snail | Snail family transcription factor | SNAI1, SNAI2, SNAI3 |
Socs36E | Suppressor of cytokine signaling at 36E | cytoplasmic suppressors of JAK/STAT signaling | SOCS4, SOCS5 |
srp | serpent | GATA-factor | hGATA4, hGATA5, hGATA6 * |
T48 | Transcript 48 | membrane protein | |
tai | taiman | Steroid receptor co-activator | AIB1 * |
Tak1 | TGF-beta activated kinase 1 | Jun kinase kinase kinase | MAP3K7 |
ths (FGF8-like1) | thisbe | FGF ligand | |
Traf6 | TNF-receptor-associated factor 6 | TNF Receptor-associated factor | |
tsr | twinstar | Cofilin/Actin Depolymerising Factor | CFL1, CFL2, ADF * |
twi | twist | Twist transcription factor | TWIST1, TWIST2 |
Uev1A | Ubiquitin-conjugating enzyme variant 1A | Part of Ben/dUev1a E2 ubiquitin-conjugating enzyme complex | UBE2V1, UBE2V2 |
Upd | Unpaired | Interleukin-like JAK/STAT ligand | IL-6 * |
upd2 | unpaired 2 | Interleukin-like JAK/STAT ligand | IL-6 * |
upd3 | unpaired 3 | Interleukin-like JAK/STAT ligand | IL-6 * |
usp | ultraspiracle | part of the EcR/Usp ecdysone receptor heterodimer | RXRA, RXRB, RXRG |
wg | wingless | WNT/Wingless secreted ligand | WNT1 |
wgn | wengen | TNF Receptor | |
zip | zipper | non-muscle myosin II |